For decades, pharmaceutical innovation focused on discovering new molecules and identifying new disease targets. Today, many of those tools already exist. Scientists can edit genes, engineer immune cells, deliver mRNA,

Healthcare R&D productivity remains largely stagnant, hampered by fragmented workflows, siloed data systems, and mounting documentation burdens that cost the industry billions in lost efficiency. Pharmaceutical R&D leaders face an

The most visible trend in cultivated pet food is not replacement, but integration. Early products rarely attempt to substitute conventional meat entirely. Instead, cultivated proteins are introduced as functional components

42% of pet owners now prioritize spending on high-quality nutrition, fueling interest in organic, natural, and minimally processed pet food. Pet parents are becoming increasingly attentive to their pets’ health.

Over 6,300 pharma startups are currently active worldwide, collectively pushing the boundaries of drug development with AI-powered platforms that can reduce discovery timelines from years to months and slash costs

Cell and gene therapies have moved decisively beyond their early experimental phase. As of 2025, over 250 gene-editing clinical trials are actively enrolling patients worldwide, with more than 150 trials

Medtronic, a leading innovator in continuous glucose monitoring, is the second-largest patent filer in this domain, trailing behind only Abbott. In terms of market share, it holds the third position,

Osteoarthritis (OA) affects ~25% of all adult dogs and up to 80% of senior dogs. In cats, this number reaches 90% at the age of twelve. While OA is more

If there’s an industry that needs AI to serve as an inflection point in its trajectory, it is drug development. Long before OpenAI opened the floodgates of the AI push,

Unlike traditional drug therapies, which often target proteins or enzymes, RNA-based treatments work by directly influencing the genetic material (RNA) in our cells. This enables precise control over gene expression,